Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00GAM
|
|||
| Former ID |
DIB003145
|
|||
| Drug Name |
Beclanorsen
|
|||
| Synonyms |
SPC-2004; SPC-2993; SPC-2996; Anti-Bcl-2 (LNA antisense therapy), Santaris
Click to Show/Hide
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 1/2 | [1] | |
| Company |
Santaris Pharma A/S
|
|||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00285103) SPC2996 in Chronic Lymphocytic Leukaemia. U.S. National Institutes of Health. | |||
| REF 2 | Combination of novel imidazopyridazine mps-1 kinase inhibitors and bcl-2 family protein inhibitors. ACS Med Chem Lett. 2014 Jul 30;6(1):7-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.